Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lebowitz

Showing results (1021-1030 of 1,066) with videos related to

Pageof 107
Sort By:
Nature Communications|December 22, 2017
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmissionDanielle O Sambo, Min Lin, Anthony Owens, et al.
The Journal of Biological Chemistry|July 31, 2020
Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiencyAmanda R Luu, Cara Wong, Vishal Agrawal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancerAnna Maria Storniolo, Mark D Pegram, Beth Overmoyer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2005
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinomaCarter Van Waes, Angela A Chang, Peter F Lebowitz, et al.
The Journal of Clinical Psychiatry|May 17, 2021
Posttraumatic Distress Symptoms and Their Response to Treatment in Adults With Prolonged Grief DisorderPeter J Na, Samrachana Adhikari, Kristin L Szuhany, et al.
The Journal of Clinical Psychiatry|May 23, 2008
Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policyCarl Salzman, Dilip V Jeste, Roger E Meyer, et al.
Journal of Veterinary Internal Medicine|May 21, 2016
Australian Cattle Dogs with Neuronal Ceroid Lipofuscinosis are Homozygous for a CLN5 Nonsense Mutation Previously Identified in Border ColliesA Kolicheski, G S Johnson, D P O'Brien, et al.
Biological Psychiatry|June 6, 2003
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)Gary S Sachs, Michael E Thase, Michael W Otto, et al.
NPJ Parkinson'S Disease|August 19, 2021
α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerabilityAbeer Dagra, Douglas R Miller, Min Lin, et al.
Behaviour Research and Therapy|December 28, 2023
Randomized trial comparing standard versus light intensity parent training for anxious youthEric A Storch, Andrew G Guzick, Daphne M Ayton, et al.
Pageof 107

Showing results (1021-1030 of 1,066) with videos related to

Sort By:
Pageof 107
Nature Communications|December 22, 2017
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmissionDanielle O Sambo, Min Lin, Anthony Owens, et al.
The Journal of Biological Chemistry|July 31, 2020
Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiencyAmanda R Luu, Cara Wong, Vishal Agrawal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancerAnna Maria Storniolo, Mark D Pegram, Beth Overmoyer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2005
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinomaCarter Van Waes, Angela A Chang, Peter F Lebowitz, et al.
The Journal of Clinical Psychiatry|May 17, 2021
Posttraumatic Distress Symptoms and Their Response to Treatment in Adults With Prolonged Grief DisorderPeter J Na, Samrachana Adhikari, Kristin L Szuhany, et al.
The Journal of Clinical Psychiatry|May 23, 2008
Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policyCarl Salzman, Dilip V Jeste, Roger E Meyer, et al.
Journal of Veterinary Internal Medicine|May 21, 2016
Australian Cattle Dogs with Neuronal Ceroid Lipofuscinosis are Homozygous for a CLN5 Nonsense Mutation Previously Identified in Border ColliesA Kolicheski, G S Johnson, D P O'Brien, et al.
Biological Psychiatry|June 6, 2003
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)Gary S Sachs, Michael E Thase, Michael W Otto, et al.
NPJ Parkinson'S Disease|August 19, 2021
α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerabilityAbeer Dagra, Douglas R Miller, Min Lin, et al.
Behaviour Research and Therapy|December 28, 2023
Randomized trial comparing standard versus light intensity parent training for anxious youthEric A Storch, Andrew G Guzick, Daphne M Ayton, et al.
Pageof 107